Global Animal Vaccine Market Size, Share & Trends Analysis Report By Type (Porcine Vaccines, Poultry Vaccines, Livestock Vaccines, Aquaculture Vaccines, Companion Animal Vaccines, and Other Animal Vaccines), By Technology (Live Attenuated Vaccines, Killed/Inactivated Vaccine, Recombinant Vaccines, and Other ) Forecast, 2022-2028
The animal vaccine market is anticipated to grow at a substantial CAGR of 6.8% during the forecast period (2022-2028). The increasing trend for the pet as a companion increases the possibility of zoonotic diseases (disease passing from animals & insects to people), which acts as one of the major factors for the growth of the market across the globe. According to the Centers for Disease Control and Prevention (CDC), zoonotic diseases are very common in the US and Europe. It is estimated that over 6 out of 10 infectious diseases in humans are spread from animals in the US. In May 2019, the CDC, in collaboration with the USDA and the U.S. Department of the Interior, released a list of the top 8 infectious diseases that can easily spread from animals to humans. These include salmonellosis, zoonotic influenza, West Nile virus, coronavirus, plague, rabies, Lyme disease, and brucellosis. Therefore, the CDC is undertaking initiatives to protect people from zoonotic diseases. This increases the demand for preventive vaccination, which in turn, fuels the demand for animal vaccines across the globe.
The constant introduction of technologically sophisticated vaccinations, as well as the spread of cattle diseases, have influenced market dynamics. The market has shifted from live attenuated vaccines to DNA vaccines, and recombinant vaccination solutions are being quickly adopted. However, the high maintenance costs for proper temperature conditions for vaccination storage and the stringent regulatory standards will affect the growth of the global animal vaccine market. Further, the side effects that can be caused by animal vaccines including toxicity, or sensitivity reaction restraint the growth of the animal vaccine market across the globe. Conversely, the vaccination campaign by the different organizations and the initiatives taken by the research institutes and animal health companies to support veterinary R&D for the animal vaccine is giving future growth opportunities to the animal vaccine market. For instance, in May 2018, Zoetis support animal health in Nigeria through a partnership with local distribution agents in combination with the newly declared African Livestock Productivity and Health Advancement (A.L.P.H.A.) initiative.
COVID-19 Impact on Global Animal vaccine Market
The global animal vaccine market was negatively affected by the COVID-19 pandemic since December 2019. All industries have been affected by the COVID-19 pandemic, including animal vaccines. Currently, the OIE has proven that this virus cannot be transferred by animals. In a few countries, however, human-to-animal transmission has been observed. During the early months of the pandemic, there was concern that it would spread through birds, posing a threat to the livestock industry. Following the significant epidemic in the US, several pig and poultry processing plants were forced to close. Fears and concerns about the new coronavirus have already cost India's chicken industry $1 billion. A bird flu outbreak was detected in nine Indian states in December 2020. As a result, the price of chicken products has dropped, negatively impacting the livestock business as a whole. As of December 2020, the Poultry Federation of India reports that chicken consumption has decreased by 50%, with prices dropping by 30%. The virus has been examined in a large number of dogs and cats by IDEXX Laboratories and other businesses, with negative findings. As per the Government of India, the demand for milk in India reduced by 20-25% during the lockdown.
The global animal vaccine market is segmented based on type and technology. Based on the type of vaccines, the market is segmented into porcine vaccines, poultry vaccines, livestock vaccines, aquaculture vaccines, companion animal vaccines, and other animal vaccines. Further, based on technology, the market is segmented into live attenuated vaccines, killed/inactivated vaccine, recombinant vaccines, and other. Among these, the recombinant vaccine segment is predicted to increase at a fast rate during the forecast period. Following vaccination, these vaccines serve to minimize the risk of pathogenicity in animals.
Global Animal vaccine Share by Type, 2020 (%)
Global Animal vaccine Share by Type
Livestock Vaccines Segment to Hold a Lucrative Share in the Global Animal Vaccine market
Amongst the type segment of the global animal vaccine market, the livestock vaccine segment is projected to grow at a substantial rate over the forecast period. The livestock segment growth is attributed to the increase in consumption of meat, milk, and dairy products, making sustainable animal health a vital aspect in disease management. In the veterinary field, live livestock is the oldest vaccination approach. This approach is also being tested for the creation of new applications. The development of protein subunit vaccines for swine that are administered intramuscularly is one of these options. These products assist to lower death rates and extend the life duration of diseased pigs. Besides, the companion animal vaccine market held the largest share in the type segment in 2020. The segmental growth is also accredited to the significant activities by the key players along with several initiatives. For instance, Bruhat Bengaluru Mahanagara Palike (BBMP), that announced to introduce the delayed mass rabies vaccination drive by mid-March 2020 and bring in dog-catchers from other states to achieve a 100% vaccination launch for stray dogs. Thus, this is likely to promote the demand for animal vaccines over the coming years.
The global animal vaccine market is analyzed based on the geographical regions that are contributing significantly to the growth of the market. Based on the geography, the market is bifurcated into North America (the US and Canada), Europe (Germany, Spain, Italy, France, the UK, and the Rest of Europe), Asia-Pacific (India, China, Japan South Korea, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East and Africa, and Latin America). North America is estimated to have one of the major shares in the animal vaccine market. The high adoption rate of pets and their mandatory vaccination are the major factors for the growth of the North American market. The increasing research on the animal vaccine to replace antibiotics and promote effective animal husbandry process can be considered as the major factor driving the market growth in Europe.
Global Animal Vaccine Market Growth, by region 2022-2028
Global Animal Vaccine Market Growth, by region
Asia-Pacific is projected to highest Contributor to the growth of the Global Animal Vaccine market
Asia-Pacific is estimated to project the fastest growth. This growth can be accredited to the continuous rise in the consumption and trade of meat in the region, especially in China. China’s increasing demand for meat is making it one of the largest markets for animal healthcare products for livestock animals. Besides, ongoing research on innovative vaccine production technology has increased due to the high demand for animal-based food products and companion animals.
Market Players Outlook
The key players of the global animal vaccine market include Boehringer Ingelheim International GmbH, Ceva Santé Animale, Virbac S.A., Zoetis Inc., Merck & Co., Inc., and Bayer AG, among others. To survive in the market these players adopt different marketing strategies such as a merger, acquisitions, product launch, and geographical expansion so on. For instance, in April 2019, Merck & Co., Inc. acquired Antelliq Group, a key player in digital animal identification, traceability, and monitoring solutions for strengthening its Animal Health segment. With this acquisition, the company witnessed an increase in the sales of livestock products by 6% in 2019.
The Report Covers
- Market value data analysis of 2020 and forecast to 2027.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global animal vaccine market based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying who-stands-where in the market.
Table of Contents
- Current Industry Analysis and Growth Potential Outlook
- Impact of COVID-19 on the Global Animal Vaccine Industry
- Recovery Scenario of Global Animal Vaccine Industry
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. Key Strategy Analysis
3.3. Impact of Covid on key players
5.1.1. Porcine Vaccines
5.1.2. Poultry Vaccines
5.1.3. Livestock Vaccines
5.1.4. Aquaculture Vaccines
5.1.5. Companion Animal Vaccines
5.1.6. Other Animal Vaccines
5.2. Global Animal Vaccine Market by Technology
5.2.1. Live Attenuated Vaccines
5.2.2. Killed/Inactivated Vaccine
5.2.3. Recombinant Vaccines
6.1.1. United States
6.2.6. Rest of Europe
6.3.4. South Korea
6.3.5. Rest of Asia-Pacific
6.4. Rest of the World
7.2. Bayer AG
7.3. Biogenesis Bago A.S.
7.4. Boehringer Ingelheim International GmbH
7.5. CevaAnimal Health LLC
7.6. Elanco Animal Health Inc. (Eli Lilly & Co.)
7.7. Hester Biosciences Ltd.
7.8. HIPRA S.A.
7.9. Hygieia Biological Laboratories
7.10. Indovax Pvt. Ltd.
7.11. Intervet International B.V.
7.12. Jinyu Bio-Technology Co, Ltd.
7.13. Merck & Co., Inc.
7.14. Neogen Corp.
7.15. Nisseiken Co. Ltd.
7.16. Phibro Animal Health Corp.
7.17. United Vaccines, Inc.
7.18. Vetoquinol S.A.
7.19. Virbac S.A.
7.20. Zoetis Inc.
A selection of companies mentioned in this report includes:
- AniCon Labor GmbH
- Bayer AG
- Biogenesis Bago A.S.
- Boehringer Ingelheim International GmbH
- CevaAnimal Health LLC
- Elanco Animal Health Inc. (Eli Lilly & Co.)
- Hester Biosciences Ltd.
- HIPRA S.A.
- Hygieia Biological Laboratories
- Indovax Pvt. Ltd.
- Intervet International B.V.
- Jinyu Bio-Technology Co, Ltd.
- Merck & Co., Inc.
- Neogen Corp.
- Nisseiken Co. Ltd.
- Phibro Animal Health Corp.
- United Vaccines, Inc.
- Vetoquinol S.A.
- Virbac S.A.
- Zoetis Inc.